These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 29432826)
21. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929 [TBL] [Abstract][Full Text] [Related]
22. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies. Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065 [TBL] [Abstract][Full Text] [Related]
23. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units. Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626 [TBL] [Abstract][Full Text] [Related]
24. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis. Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536 [TBL] [Abstract][Full Text] [Related]
25. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC). Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849 [No Abstract] [Full Text] [Related]
26. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554 [TBL] [Abstract][Full Text] [Related]
27. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830 [TBL] [Abstract][Full Text] [Related]
28. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains. Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255 [TBL] [Abstract][Full Text] [Related]
29. Candidemia and invasive candidiasis in adults: A narrative review. Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927 [TBL] [Abstract][Full Text] [Related]
30. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia. Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667 [TBL] [Abstract][Full Text] [Related]
32. [The 1,3-β-d-glucan in critical adult patients as diagnostic tool for invasive Candida spp. infection, performance evaluation]. Donato L; González T; Canales M; Legarraga P; García P; Rabagliati R Rev Chilena Infectol; 2017 Aug; 34(4):340-346. PubMed ID: 29165510 [TBL] [Abstract][Full Text] [Related]
33. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia. White PL; Price JS; Posso RB; Barnes RA Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117 [TBL] [Abstract][Full Text] [Related]
34. Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa. Chibabhai V; Fadana V; Bosman N; Nana T Mycoses; 2019 Nov; 62(11):1023-1028. PubMed ID: 31393662 [TBL] [Abstract][Full Text] [Related]
35. Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study. Farooqi J; Niamatullah H; Irfan S; Zafar A; Malik F; Jabeen K Clin Microbiol Infect; 2021 Oct; 27(10):1519.e1-1519.e5. PubMed ID: 34111581 [TBL] [Abstract][Full Text] [Related]
36. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy. Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196 [TBL] [Abstract][Full Text] [Related]
37. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital. Agnelli C; Bouza E; Del Carmen Martínez-Jiménez M; Navarro R; Valerio M; Machado M; Guinea J; Sánchez-Carrillo C; Alonso R; Muñoz P Clin Infect Dis; 2020 Apr; 70(9):1925-1932. PubMed ID: 31680136 [TBL] [Abstract][Full Text] [Related]
39. Use of T2MR in invasive candidiasis with and without candidemia. Zacharioudakis IM; Zervou FN; Mylonakis E Future Microbiol; 2018 Aug; 13():1165-1173. PubMed ID: 29792512 [TBL] [Abstract][Full Text] [Related]
40. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]